Clinical Trials Scientific Review Committee

The Clinical Trials Scientific Review Committee (CT-SRC) is responsible for scientific review of clinical protocols, including:

• Scientific rationale
• Study design
• Appropriateness of biostatistical endpoints

It monitors the progress of all institutional protocols to ensure:

• That they adhere to the initial study design
• That planned patient accrual is occurring
• That planned stopping criteria are followed
• That any observed toxicities are consistent with those expected 

The CT-SRC has the authority to suspend or close protocols that fail to meet these requirements.